A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease

NCT00862641 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1009

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma
Coronary Artery Disease
Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Regadenoson
DRUG: Placebo

Sponsor

Astellas Pharma Inc